Evidence of the role of trazodone in patients affected by major depressive disorder with anxiety symptoms, insomnia, agitation, cognitive deficits, alcohol use disorders, physical comorbidities, and suicide risk has been identified, showing the effectiveness of trazodone in different presentations of major depressive disorder. The main characteristics of patients with depression for whom trazodone seems to be most effective have been identified, providing clinicians with information on possible uses of this drug in such population of patients.
Keyphrases
- major depressive disorder
- bipolar disorder
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- sleep quality
- prognostic factors
- randomized controlled trial
- systematic review
- mental health
- emergency department
- depressive symptoms
- healthcare
- physical activity
- social media
- health information
- drug induced